Brief: Quantum Genomics Eyes Firibastat's Market Debut At End Of 2023

Quantum Genomics SA

07/10/2021 17:17

Oct 7 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS AND ITS PARTNERS REACH A NEW STAGE OF DEVELOPMENT IN ASIA
    * PHASE III REFRESH STUDY HAS BEEN APPROVED BY REGULATORY AUTHORITIES AND
ETHICS
COMMITTEES IN SOUTH KOREA AND TAIWAN
    * PRE-MARKETING ACTIVITIES HAVE BEEN INTENSIFIED WITH OEP AND DONGWHA
    * TIMELINES FOR BOTH FRESH AND REFRESH STUDIES ARE PERFECTLY ALIGNED WITH
AIM OF
PUTTING FIRIBASTAT ON MARKET AT END OF 2023
    * MILESTONE PAYMENTS FROM OUR PARTNERS ARE EXPECTED BY YEAR-END 


Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))